Category: by author

Three expressions of concern added to cancer researcher’s notice list

3.coverQuestions about data and conclusions in papers by a cancer researcher at the University of Maryland have led to three expressions of concern in the Journal of Biological Chemistry.

The notices follow four retractions — two for image duplications and two for unknown reasons — for Anil K. Jaiswal. The three papers under notice are all on mechanisms that regulate gene expression; PubPeer commenters have raised questions about some of the figures in the papers.

The expression of concern on all three papers reads, in full:

Continue reading Three expressions of concern added to cancer researcher’s notice list

Anonymous complaint about Dutch economist is “unfounded”: Report

Peter Nijkamp
Peter Nijkamp

Vrije Universiteit Amsterdam (VU) has dismissed an anonymous accusation against economist Peter Nijkamp and two of his colleagues, including one of his graduate students, regarding issues related to “data acquisition and data processing.”

The announcement, released last week, determined the latest complaint was “unfounded:” Continue reading Anonymous complaint about Dutch economist is “unfounded”: Report

Court denies appeal of HIV fraudster’s 57-month prison sentence

court caseAn appeals court has affirmed the stiff prison sentence for Dong-Pyou Han, the former Iowa State University researcher who faked the results of an HIV vaccine experiment in rabbits. Continue reading Court denies appeal of HIV fraudster’s 57-month prison sentence

Why retraction shouldn’t always be the end of the story

rsc-logoWhen researchers raised concerns about a 2009 Science paper regarding a new way to screen for enzymatic activity, the lead author’s institution launched an investigation. The paper was ultimately retracted in 2010, citing “errors and omissions.”

It would seem from this example that the publishing process worked, and science’s ability to self-correct cleaned up the record. But not so to researchers Ferric Fang and Arturo Casadevall.

Fang, of the University of Washington, Seattle, and Casadevall, of Johns Hopkins — who have made names for themselves by studying retractions — note today in an article for Chemistry World that

Continue reading Why retraction shouldn’t always be the end of the story

Voinnet’s notice count grows, as he notches his 18th correction

home_coverOlivier Voinnet, a high-profile plant scientist at ETH Zurich, has earned a mega-correction. It wrapped up a rough year for the biologist, which included his seventh retraction, and a CNRS investigation that found evidence of misconduct.

This latest correction, to a paper on the mechanisms behind RNA silencing in Arabidopsis, was published in RNA. The 2007 paper has been cited 101 times, according to Thomson Scientific’s Web of Knowledge. The corrigendum modifies three figures in total.

The notice is long, so we’re not going to post the whole thing here. The first error in “Transitivity in Arabidopsis can be primed, requires the redundant action of the antiviral Dicer-like 4 and Dicer-like 2, and is compromised by viral-encoded suppressor proteins” is a clarification to a legend:

Continue reading Voinnet’s notice count grows, as he notches his 18th correction

Cancer researcher cleared of misconduct, inquiry finds “genuine error or honest oversight”

Khachigian
Levon Khachigian

An investigation at the University of New South Wales in Australia has determined that a long-accused cancer researcher did not commit misconduct.

The investigation did find instances when Levon Khachigian breached the code of conduct, but Continue reading Cancer researcher cleared of misconduct, inquiry finds “genuine error or honest oversight”

7th retraction for heart researcher who faked patient records

1.coverAnna Ahimastos, a heart researcher who faked patient records, has notched her 7th retraction.

One more paper is expected to be retracted, according to a spokesperson from her former institution, the Baker IDI Heart & Diabetes Institute in Australia.

As with the other retractions, the 2005 paper in Hypertension — about how the hypertension drug ramipril may help alleviate cardiovascular disease — is being pulled after Ahimastos admitted to scientific misconduct. She asserts the data remain valid, and has not signed the retraction notice.

The Hypertension paper has been cited 63 times, according to Thomson Scientific’s Web of Knowledge. Here’s the retraction note in full (the language will be familiar to readers who have been following this case):

Continue reading 7th retraction for heart researcher who faked patient records

Cancer research pioneer Robert Weinberg corrected Oncogene paper

onc_cimageRobert Weinberg, a prominent cancer researcher at the Whitehead Institute, issued a correction to a paper in Oncogene in May, fixing two errors missed during proofing.

We found this one a little late, obviously. It also appears to be a relatively minor correction, not one that appears worthy of retraction. We’ve gotten feedback from readers asking why we cover corrections; we chose to flag this one because Weinberg has had such an impact on his field — he discovered the first tumor-causing gene in humans, as well as the first tumor-suppressor gene — and his papers are often highly cited. He also has issued five retractions in the past, most of which for papers whose first author was a member of his lab, who is not a co-author on the Oncogene paper.

Here’s the correction note for “Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells:”

Continue reading Cancer research pioneer Robert Weinberg corrected Oncogene paper

Five years after a retraction, company’s stock is up more than 500%

wntloggawntresearchwebny1Is ethical behavior good for business?

Five years ago this month, Swedish pharmaceutical company WntResearch immediately notified shareholders when authors retracted a 2009 Proceedings of the National Academy of Sciences (PNAS) paper on a potential cancer therapy that was key to the company’s business.

At the time, the company’s decision to disclose the retraction hurt its finances, as WntResearch delayed its planned initial public offering for three weeks. It also offered investors and shareholders the opportunity to withdraw their shares of WntResearch stock.

But, aside from one of the paper’s co-authors, “No one did that,” Nils Brünner, WntResearch’s CEO, told us. Since the company’s IPO on December 17, 2010, its stock price has increased from Continue reading Five years after a retraction, company’s stock is up more than 500%

Diederik Stapel now has 58 retractions

stapel_npcSocial psychologist Diederik Stapel has notched his 58th retraction, after admitting he fabricated data in yet another article.

He’s holding onto his 4th place spot on our leaderboard.

This latest retraction is for “Correction or comparison? The effects of prime awareness on social judgments,” published in the European Journal of Social Psychology. As usual for Stapel, this paper has been retracted because he fabricated data.

Here’s the note:

Continue reading Diederik Stapel now has 58 retractions